VBI Vaccines will immediately have access to up to $50 million (all terms U.S.) in cash, consisting of $30 million in refinanced funding as well as $20 million in new financing.
Orléans-based company has spent years developing drugs designed to mimic the pain-killing and anti-inflammatory benefits of cannabis without major side effects.
Ottawa startup awaiting regulatory approval for portable device says partnership with world-renowned U.S. research facility will help further develop its technology.
The pressure is on for small businesses that are grappling with high inflation and facing increased interest rates for loan repayments, Ottawa accountant says.
Business supports were excessive and show the outsized influence of business groups on public policy, economists say.
If workers are leaving their jobs, where are they going? Back to school. Back to yoga. Toward public office, Uber driving, sales and writing. These are their stories.
Ottawa biotech startup has raised $7.5 million in fresh funding as it looks to capitalize what it says is the continued need for "a decentralized, laboratory-quality" test kit.
Governments have been loosening COVID-19 restrictions, with Ottawa allowing airline and railway workers as well as passengers to climb on board without being jabbed starting Monday.
Ian McGrath has made it clear to his bosses: If the company forces staff to return to the office, he'll tender his resignation.
Air Canada more than tripled its revenues last quarter as demand for travel revved back up, though a net loss of nearly $1 billion signalled the pandemic recovery is far from complete.